An Enzyme Self-Amplification System for Ultrasensitive Detection of Biomarkers at the Point of Care
An Enzyme Self-Amplification System for Ultrasensitive Detection of Biomarkers at the Point of Care
批准号:
10463564
负责人:
Catherine E. Majors
金额:
$6.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2023-06-30
关键词:
Adenylate CyclaseAntibodiesAntigensAutomobile DrivingBase PairingBindingBinding ProteinsBiological AssayBiological MarkersBiologyChimeric ProteinsClinicalCommunicable DiseasesCommunication ResearchComplexComputer ModelsConcentration measurementCritical ThinkingCyclic AMPCyclic AMP Receptor ProteinDNADetectionDiagnosisDiagnosticDiagnostic EquipmentDifferential EquationDiseaseEducational process of instructingEngineeringEnsureEnzyme KineticsEnzymesEquipmentFeedbackFutureGenerationsGoalsHumanIn VitroInstitutesKineticsManuscriptsMeasuresMentorshipMethodsModelingPathway interactionsPost-Translational Protein ProcessingPostdoctoral FellowPreparationProductionPromoter RegionsPropertyProtein EngineeringProteinsRapid diagnosticsResearchResearch PersonnelResourcesSamplingSignal TransductionSignaling ProteinSirolimusSystemTacrolimus Binding Protein 1ATertiary Protein StructureTestingTrainingUniversitiesWorkbasecareercareer networkingclinically relevantclinically translatabledesigndetection methoddetection platformenzyme reconstitutionglobal healthin vivoinnovationlateral flow assaymodel designnovelnucleic acid detectionpoint of carepreventprotein complexreconstitutionresponsesensorskillssmall moleculesuccesssynthetic biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Rapid, inexpensive detection of biomarkers at the point of care is vital for many clinical purposes. However,
limitations in current detection platforms have prevented the sensitive detection of many protein and small
molecule biomarkers, forcing clinicians to rely either potentially inaccurate empirical diagnosis or expensive lab
tests to make critical treatment decisions. Sensitive detection of nucleic acid targets has been readily achieved
by exploiting Watson-Crick base pairing to amplify signals (PCR, LAMP, Cas9, etc.), but there has been a lack
of innovation for detection of low concentration antigens and small molecules at the point of care. Biology has
evolved intricate mechanisms for rapidly amplifying protein signals in vivo via post-translational modification
and protein based signaling networks. Towards the goal of developing novel, rapid, ultrasensitive diagnostics,
the central hypothesis of this project is that in vitro, protein-based signaling networks incorporating self-
amplifying enzymatic pathways will result in biomarker detection platforms with unparalleled sensing
capabilities. Specifically, we plan to investigate two mechanisms of protein signaling networks with potential for
diagnostics: split enzyme reconstitution and autocatalytic positive feedback loops. First, we will investigate the
in vitro use of split adenylate cyclase for small molecule detection. Detection of the analyte will be
accomplished by the simultaneously binding two proteins (i.e. a sandwich assay in solution), bringing two
halves of adenylate cyclase together and producing cAMP. Second, we will investigate fusions of split
adenylate cyclase and cAMP receptor protein to create an autocatalytic feedback loop in vitro. This loop will
respond to cAMP by producing more cAMP. Finally, we will develop ordinary differential equation-based
models to understand and engineer diagnostic properties. Dynamic models of these protein-signaling networks
will be informed by measured experimental parameters. These models will be used to create a combined
model for a high sensitivity, fast small molecule sensor as a proof-of-principle for future work. If successful, this
system would be broadly applicable for protein and small molecule detection and could be used to detect a
wide range of target analytes with known antibody binding domains. As such, this system could be used as a
platform for the detection of many protein and small molecule analytes currently unable to be rapidly detected
at the point of care. Over the course of the project the fellow will receive technical training in synthetic biology
methods, protein engineering, and kinetics computational modeling, in addition to career training in teaching
and mentorship best practices, manuscript preparation, grantsmanship, and research communication from the
sponsor and co-sponsor and resources available through institutes at Northwestern University. Additionally, the
trainee will have the opportunity build a strong professional network of synthetic biologists, diagnostic design
experts, and global health clinicians over the course of her training and will continue developing the proposed
detection platform into clinically translatable diagnostic devices as an independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Novel Split Enzyme Diagnostic Platform for Use at the Point of Care
-
批准号:10723565
-
项目类别:
-
资助金额:$10.79万
-
财政年份:2023
-
负责人:Catherine E. Majors
-
依托单位:
海外基金